key: cord-0781475-ug48j05i
authors: Schulze, H.; Hoffmann, D.; Bayer, W.
title: Symptom-based prediction model of SARS-1 CoV-2 infection developed from self-reported symptoms of SARS-CoV-2-infected individuals in an online survey
date: 2020-11-29
journal: nan
DOI: 10.1101/2020.11.25.20236752
sha: 517f029e4be121de24d2eb895e37dcf5b96e786e
doc_id: 781475
cord_uid: ug48j05i

Background: Infections with the newly emerged severe acute respiratory syndrome virus 2 (SARS-CoV-2) have quickly reached pandemic proportions and are causing a global health crisis. First recognized for the induction of severe disease, the virus also causes asymptomatic infections or infections with mild symptoms that can resemble common colds. Since infections with mild course are probably a major contributor to the spread of SARS-CoV-2, better detection of such cases is important. To provide better understanding of these mild SARS-CoV-2 infections and to improve information for potentially infected individuals, we performed a detailed analysis of self-reported symptoms of SARS-CoV-2 positive and SARS-CoV-2 negative individuals. Methods: In an online-based survey, 963 individuals provided information on symptoms associated with an acute respiratory infection, 336 of the participants had tested positive for SARS-CoV-2 infection, 107 had tested negative, and 520 had not been tested for SARS-CoV-2 infection. Results: The symptoms reported most frequently by SARS-CoV-2 infected individuals were tiredness, loss of appetite, impairment of smell or taste and dry cough. The symptoms with the highest odds ratios between SARS-CoV-2 positive and negative individuals were loss of appetite and impairment of smell or taste. Based on the most distinguishing symptoms, we developed a Bayesian prediction model, which had a positive predictive value of 0.80 and a negative predictive value of 0.72 on the SARS-CoV-2 tested individuals. The model predicted 56 of 520 non-tested individuals to be SARS-CoV-2 positive with more than 75% probability, and another 84 to be SARS-CoV-2 positive with probability between 50% and 75%. Conclusions: A combination of symptoms can provide a good estimate of the probability of SARS-CoV-2 infection.

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus 50 associated with the coronavirus infectious disease 19 , at the end of 2019 [1] has 51 quickly developed into pandemic proportions and was declared a public health emergency of 52 international concern by the World Health Organization on January 30 th 2020 [2] . The first 53 infections in Europe occurred in Italy and Germany in late January 2020 [3] . By March 2020, 54 SARS-CoV-2 infection rose rapidly in many countries, and have started to do so again with 55 the fall season in the northern hemisphere; as of November 6 th 2020, more than 48 million 56 people have been infected by SARS-CoV-2, and more than 1.2 million SARS-CoV-2 related 57 deaths have been reported [4] . 58

Due to the rapid rise in demand for SARS-CoV-2 diagnostic tests and a resulting shortness of 59 supplies, not all patients could be given access to SARS-CoV-2 testing in spring 2020, and a 60 pre-screening was performed on the basis of symptoms, and prior residence in SARS-CoV-2 61 risk areas or prior contact to individuals who had tested SARS-CoV-2 positive. The lack of 62 access to testing led to many uncertainties for patients with cold symptoms. From the first 63 cases in China, the typical symptoms of SARS-CoV-2 infection were described as dry cough, 64 fever, and pneumonia [5, 6] . These first reports of symptoms associated with SARS-CoV-2 65 infection / COVID-19 were based on symptoms found in hospitalized patients with severe 66 disease. Notably, in the first reports on COVID-19, disease course was considered mild if 67 patients did not require ventilation. It soon became obvious though that many SARS-CoV-2 68 infected individuals experienced asymptomatic or now commonly considered non-severe 69 disease course that resembled common colds and did not require hospitalization [7] . Since the 70 hospitalized and critically ill patients were of the greatest concern in the early days of the 71 pandemic, the range of symptoms of SARS-CoV-2 infected individuals with mild symptoms 72 was not the focus of attention. In following studies, it has been found that many SARS-CoV-2 73 infected patients experienced altered or completely lost sense of smell and / or taste [8, 9] , 74 which has since been regarded as a key indicator of SARS-CoV-2 infection. 75

To get a more detailed picture of the symptoms of SARS-CoV-2 infection, we created an 76

online questionnaire and invited both tested and untested individuals to report their symptoms. 77

The symptoms included in the survey comprised general symptoms such as fever, fatigue, 78 headache and joint or muscle pains, and more specific eye, nose, throat, respiratory and 79 gastrointestinal symptoms. The self-reported symptoms of SARS-CoV-2 positive-and 80 negative-tested individuals were then used to fit a Bayesian model, which was used to predict 81 probabilities of a SARS-CoV-2 infection of the non-tested survey participants. 82 83 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 

Data were collected in an online questionnaire based on LimeSurvey software hosted on the 86 servers of the University of Duisburg-Essen. Participants of the online survey were recruited 87 via public health offices of the city of Hamm (Northrhine-Westphalia, Germany), of the 88 administrative district Soest (Northrhine-Westphalia, Germany), of the administrative district 89

Hochsauerland (Northrhine-Westphalia, Germany) and the SARS-CoV-2 testing center in 90

Lünen, administrative district Unna (Northrhine-Westphalia, Germany), as well as via social 91 media. Participants were invited to complete the survey in case of a positive as well as 92 negative SARS-CoV-2 test result, and also if they had not been tested but had cold symptoms. 93

The data were collected between April 6 th and September 1 st 2020. 94

Data were analyzed using R (version 3.6.3) and RStudio software and fsmb, plyr, splyr, 96 tidyverse, randomForest, patchwork, rstanarm, ROCR, ggplot2, viridis and bayesplot 97 packages. Only data from individuals who had completed the survey were included in the 98

For graphic representation of the survey results of tested individuals, data were sorted for the 100 SARS-CoV-2 test result, the severity of the SARS-CoV-2 symptoms and the severity of fever 101 using the tidyverse package, and a heatmap of the survey data was generated using ggplot2 102 package. 103

Frequencies of individual symptoms were calculated and visualized as heatmap using ggplot2 104 and viridis package. Odds ratios for individual symptoms were calculated as the conditional 105 maximum likelihood estimate with 90% confidence interval using the pairwise.fisher.test 106 command of R package fsmb, results were visualized using ggplot2. 107 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 Random Forest analysis of the survey data was performed using R package randomForest 4.6-108 were calculated using the Voila online tool [14] , which is based on a Bayesian classifier 125 uncertainty estimate method [15] . 126

For prediction of SARS-CoV-2 infection in untested individuals, the Bayesian model was 127 applied to the dataset from the untested individuals and the most likely SARS-CoV-2 128 infection state was calculated for each of these individuals. For visualization of the prediction 129 outcome, a heatmap was generated using ggplot2 after sorting the non-tested individuals by 130

To obtain an overview of the subjective symptoms reported by SARS-CoV-2 infected 134 individuals, an online survey was performed. Invitations to the survey were published on 135 social media, and SARS-CoV-2 tested individuals were also directly invited to participate 136 when they received notification of their test results, or by subsequent invitation, by local 137 public health offices. Participants included both tested individuals, as well as non-tested 138 individuals, who were considered separately in the analysis of the survey. The characteristics 139 of the tested study population are represented in Table The symptoms reported by the tested study population are shown as a heatmap in Figure 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint both SARS-CoV-2 positive and negative individuals, whereas most SARS-CoV-2 positive 158 individuals did not report other throat symptoms including throat pain. Approximately one 159 third of individuals reported breathing problems, and also diarrhea was reported by 160 approximately a third of SARS-CoV-2 positive and negative individuals. 161

The frequency of symptoms in SARS-CoV-2 positive and negative individuals were used to 162 calculate the odds ratios for the individual symptoms ( Figure 2B ). Since the distribution of 163 many symptoms was similar in SARS-CoV-2 positive and negative individuals, many odds 164 ratios are close to 1. Clearly, the highest odds ratios were observed for impaired or lost sense 165 of smell (estimate: 4.7; 90% confidence interval (CI): 2.8 -8.1) and impaired or lost sense of 166 taste (4.3; 90% CI: 2.6 -7.2), whereas the other nose symptoms as well as eye and throat 167 symptoms were found to have odds ratios below 1. The lowest odds ratios were observed for 168 throat pain and burning sensation in the throat. The odds ratio of dry coughing is also slightly 169 below 1 (0.9; 90% CI: 0.6 -1.5), which may likely be an underestimation due to a bias in 170 eligibility criteria at the time of testing. 171

For the development of a prediction model, we performed a Bayesian regression analysis of 172 all symptoms and plotted them with their odds ratio in combination with the overall frequency 173 ( Figure 3A ). As we have an imbalanced data set with less negative than positive tests, the 174 resulting model would have been biased towards positive predictions. To avoid this, we fitted 175 the model with two different approaches. In one, we increased the number of negatives by 176 bootstrapping to match the number of positives, in the other we decreased the number of 177 positives to match the number of negatives. Both approaches gave comparable results, but we 178 favored the first one as it uses all the available data and is less prone to the introduction of a 179 bias due to sample selection. For the final model, we selected symptoms that had marginal 180 posterior probabilities of 90% or more to be either positively or negatively associated with 181 positive or negative test results with mean posterior probabilities of > 0.5 or < -0.5 in the 182 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ;

Bayes regression analysis, and were reported by at least 20% of the positive or negative 183 individuals. We also performed a random forest regression analysis ( Figure 3B ), which 184 confirmed the importance of the selected symptoms. 185

Based on these analyses, we selected the ten symptoms impaired or lost sense of smell, throat 186 pain, loss of appetite, joint pain, runny nose, muscle pain, headache, fever higher than 187 38.5 °C, tiredness and chills. As stated above, the high representation of dry cough in SARS-188

CoV-2 uninfected symptomatic individuals is likely due to the fact that it was communicated 189 very early on as a typical symptom of SARS-CoV-2 infection, and was therefore a criterion 190 for testing. Furthermore, we observed a strong correlation between impaired or lost sense of 191 taste and sense of smell (Pearson's r = 0.72). Therefore, neither dry cough nor loss of taste 192 were included in the final Bayes model. 193

We used the selected ten symptoms to fit the final Bayesian regression model ( Figure 4A ). On 194 the tested cohort data set, the model gave an area under the receiver operating characteristic 195 curve of 0.80 (AUC; Figure 4B Table 1 . In 199 total, responses of 520 participants who had not been tested for SARS-CoV-2 infection were 200 included in the survey. Using the Bayesian model described above, we calculated that 56 201 (10.8%) were SARS-CoV-2 positive with a probability of more than 75% ( Figure 4C ). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint

The data presented here provide a very detailed picture of the symptoms experienced by 208 SARS-CoV-2 infected individuals. To our knowledge, we are providing the most detailed 209 symptoms overview reported so far, having queried 45 symptoms ranging from general 210 symptoms to specific eye, nose, throat, respiratory and gastrointestinal symptoms. 211

The data collected in this survey show that a range of symptoms is observed in a majority of 212 patients, such as an impaired or lost sense of smell or taste, tiredness, lethargy, loss of 213 appetite, joint or muscle pains and dry coughing. For some symptoms, we found surprisingly 214 low frequencies in infected individuals and therefore low odds ratios, including all throat 215 symptoms other than dry cough. Furthermore, only roughly one fifth of SARS-CoV-2 216 infected individuals experienced throat pain, which could be expected to be much higher since 217 virus is routinely identified in throat swabs, showing that it is indeed infecting throat tissue. 218

For some symptoms, a bias may have been introduced into the dataset at two levels: some 219 symptoms had been described early in the pandemic as typical for SARS-CoV-2 infection, 220 and have therefore been criteria for testing, and on the other hand, the presence of these 221 symptoms and the testing procedure itself may have increased the awareness of the affected 222 individuals and increased their motivation to participate in this study. We expect that such a 223 bias might exist for the symptoms "dry cough" and "difficulty breathing". The odds ratios 224 reported here may therefore be underestimates. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint negative predictive value is lower (0.72). When used in the future for personal risk 232 assessment, a predicted low probability of SARS-CoV-2 infection should therefore still be 233 interpreted with caution and personal protection measures should be maintained. 234

Other studies have been performed investigating symptoms of SARS-CoV-2 and their 235 predictive value. Studies in the early days of the COVID-19 pandemic were reporting 236 symptoms of hospitalized patients and thus missed the symptoms that are associated with 237 mild disease courses [5, 6, 16] . Since then, multiple other studies have been performed that 238 focused on the symptoms experienced by SARS-CoV-2 infected individuals at a community 239 level [8, 9, [17] [18] [19] [20] [21] . A large study has been performed using a mobile phone app that had more 240 than seven thousand SARS-CoV-2 tested participants from the United Kingdom and the 241 United States [19] . In this study, the authors found frequencies for the symptoms "loss of 242 smell and taste", "fever", "skipped meals" and "diarrhea" that are comparable to the 243 frequencies reported by us and reported positive odds ratios for these symptoms, with the 244 highest odds ratio for "loss of smell and taste". The authors report a similar frequency of 245 "persistent cough" in the SARS-CoV-2 positive individuals as we found for "dry cough"; in 246 contrast to our data, the frequency in SARS-CoV-2 negative individuals was lower than in our 247 cohort, leading to a low positive odds ratio for the persistent cough, in contrast to our 248 findings. The authors provided a prediction model based on age, sex, loss of smell and taste, 249 persistent cough, severe fatigue and skipped meals, which obtained a positive predictive value 250 of 0.69 and a negative predictive value of 0.75. 251

In another large study, only a small number of symptoms were surveyed: sore throat, cough, 252 shortness of breath, loss of smell or taste, and fever [20] . Interestingly, the authors report 253 distinctly lower frequencies for all these symptoms in their SARS-CoV-2 infected individuals, 254 which were mostly only half of the frequencies we observed in our study and as low as only 255 2% of respondents reporting a fever of 38°C or higher, compared to more than 33% observed 256 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint by us. This study also included a large number of individuals who were COVID-19 257 undiagnosed, who were ten times the number of diagnosed individuals, however more than 258 95% of the undiagnosed individuals reported to feel well and not have any of the queried 259 symptoms, creating an imbalance between the SARS-CoV-2 positive and negative study 260 population. The model proposed in that study that relies on this small number of symptoms 261 would likely prove less effective when applied to a cohort comprising more symptomatic 262 individuals. 263

In contrast to these two large-scale studies, we did not include age and sex in our models but 264 included more symptoms, which resulted in a higher positive predictive value. Some of the 265 symptoms included in our model are more subjective and may vary in strength, for example 266 tiredness and loss of appetite. However, we think that modeling a prediction on this higher 267 number of symptoms provides a more precise model that can be used for a first prediction of 268 the probability of SARS-CoV-2 infection, guiding decisions for self-isolation and testing. 269 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint

The study was approved by the local Ethics Committee of the Medical Faculty of the 280 University Duisburg-Essen (approval number 20-9233-BO) 281

Not applicable 283

The datasets used and/or analyzed during the current study are available from the 285 corresponding author on reasonable request. 286

The authors declare that they have no competing interests. 288

The study was supported by a grant from the Stiftung Universitätsmedizin Essen to WB. 290

HS recruited participants, analyzed data and contributed to writing the manuscript. DH 292 analyzed data and contributed to writing the manuscript. WB conceived of the study, created 293 the online survey, analyzed data and wrote the manuscript. 294

The authors thank all study participants for taking the time to complete the online 296 questionnaire and contributing to our advancement in the recognition of SARS-CoV-2 297 symptoms. The authors also thank the employees of the public health offices in Hamm 298 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 (Germany), Soest (Germany), Hochsauerlandkreis (Germany) and Dr. Hüning and nurses of 299 the SARS-CoV-2 treatment center in Lünen (Germany) for distributing invitations to the 300 online survey. 301 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10. 1101 /2020 Tables 367 Table 1 . Characteristics of study cohort. 368 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101 /2020 doi: medRxiv preprint Figure 1 gastrointestinal respiratory throat symptoms nose symptoms eye symptoms general symptoms no not feverish < 37,5 °C feverish 37, 6 -38,0 °C 38,1 -38,5 °C 38,6 -39,0 °C 39,1 -39,5 °C 39,6 -40,0 °C 40,1 -40,5 °C 40,6 -41 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10. 1101 /2020 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10.1101/2020.11.25.20236752 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 29, 2020. ; https://doi.org/10. 1101 /2020 

Request for Information 303

First cases of coronavirus 309 disease 2019 (COVID-19) in the WHO European Region

Weekly Operational Update on COVID-19

Hui DSC 315 et al: Clinical Characteristics of Coronavirus Disease 2019 in China

318 Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Duration of viral shedding in asymptomatic or mild cases of novel 322 coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital 323 experience in Tokyo

Self-reported Olfactory and Taste 326 Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A 327 Cross-sectional Study

Epidemiological and clinical 330 characteristics of SARS-CoV-2 infections at a testing site in

rstanarm: Bayesian applied regression modeling via Stan

Visualization in Bayesian 337 workflow

ROCR: visualizing classifier 339 performance in R